BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27837159)

  • 1. Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays.
    Holzer TR; O'Neill Reising L; Credille KM; Schade AE; Oakley GJ
    J Histochem Cytochem; 2016 Dec; 64(12):785-810. PubMed ID: 27837159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET.
    Wagner M; Wuest M; Hamann I; Lopez-Campistrous A; McMullen TPW; Wuest F
    Nucl Med Biol; 2018 Mar; 58():51-58. PubMed ID: 29367096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
    Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
    Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma.
    Matsuo K; Nishimura M; Komurov K; Shahzad MM; Ali-Fehmi R; Roh JW; Lu C; Cody DD; Ram PT; Loizos N; Coleman RL; Sood AK
    Gynecol Oncol; 2014 Jan; 132(1):166-75. PubMed ID: 24183729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet-derived growth factor receptor α by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer.
    Laing N; McDermott B; Wen S; Yang D; Lawson D; Collins M; Reimer C; Hall PA; Andersén H; Snaith M; Wang X; Bedian V; Cao ZA; Blakey D
    Mol Pharmacol; 2013 Jun; 83(6):1247-56. PubMed ID: 23558446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy.
    Wehler TC; Frerichs K; Graf C; Drescher D; Schimanski K; Biesterfeld S; Berger MR; Kanzler S; Junginger T; Galle PR; Moehler M; Gockel I; Schimanski CC
    Oncol Rep; 2008 Mar; 19(3):697-704. PubMed ID: 18288404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated ERCC1 immunohistochemistry in non-small cell lung cancer: comparison of anti-ERCC1 antibodies 8F1, D-10, and FL-297.
    Arbogast S; Behnke S; Opitz I; Stahel RA; Seifert B; Weder W; Moch H; Soltermann A
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):99-105. PubMed ID: 21030862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated PDGFR alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size.
    Ben Jemii N; Tounsi-Kettiti H; Yaiche H; Mezghanni N; Jaballah Gabteni A; Fehri E; Ben Fayala C; Abdelhak S; Boubaker S
    J Transl Med; 2020 Nov; 18(1):440. PubMed ID: 33213472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and applications of a newly developed rabbit monoclonal antibody to cytokeratin 7 (CK7) for immunohistochemistry.
    Qi W; Chu J; Zhou D; Tacha D
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):233-8. PubMed ID: 19098679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.
    Matei D; Emerson RE; Lai YC; Baldridge LA; Rao J; Yiannoutsos C; Donner DD
    Oncogene; 2006 Mar; 25(14):2060-9. PubMed ID: 16331269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
    Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
    McLaughlin J; Han G; Schalper KA; Carvajal-Hausdorf D; Pelekanou V; Rehman J; Velcheti V; Herbst R; LoRusso P; Rimm DL
    JAMA Oncol; 2016 Jan; 2(1):46-54. PubMed ID: 26562159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A robust immunohistochemical assay for detecting PTEN expression in human tumors.
    Sangale Z; Prass C; Carlson A; Tikishvili E; Degrado J; Lanchbury J; Stone S
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):173-83. PubMed ID: 20930614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors.
    Bahamon BN; Gao F; Danaee H
    Arch Pathol Lab Med; 2016 Dec; 140(12):1397-1403. PubMed ID: 27610644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of monoclonal and polyclonal immunohistochemical staining for West Nile virus in various organs from American crows (Corvus brachyrhynchos).
    Smedley RC; Patterson JS; Miller R; Massey JP; Wise AG; Maes RK; Wu P; Kaneene JB; Kiupel M
    BMC Infect Dis; 2007 May; 7():49. PubMed ID: 17537263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?
    Kerr KM; Tsao MS; Nicholson AG; Yatabe Y; Wistuba II; Hirsch FR;
    J Thorac Oncol; 2015 Jul; 10(7):985-9. PubMed ID: 26134220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer.
    Phillips T; Simmons P; Inzunza HD; Cogswell J; Novotny J; Taylor C; Zhang X
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):541-9. PubMed ID: 26317305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas.
    Ribom D; Andrae J; Frielingsdorf M; Hartman M; Nistér M; Smits A
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):782-7. PubMed ID: 12023424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.
    Moroncini G; Cuccioloni M; Mozzicafreddo M; Pozniak KN; Grieco A; Paolini C; Tonnini C; Spadoni T; Svegliati S; Funaro A; Angeletti M; Gabrielli A
    Anal Biochem; 2017 Jul; 528():26-33. PubMed ID: 28450104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.